葛根素对小鼠脑缺血再灌注损伤的神经保护作用及机制研究

doi:10.3969/j.issn.1673-5765.2018.01.012

摘要/Abstract

摘要：

目的观察葛根素对脑缺血再灌注小鼠的神经保护作用并探讨其对雌激素受体（estrogen receptor， ER）及缺氧诱导因子-1（hypoxia inducible factor-1，HI F-1）表达及相关炎症因子释放的影响。方法 C57BL小鼠随机分为假手术组、溶剂对照组以及葛根素低剂量组（100 mg·kg-1）、中剂量组（250 mg·kg-1）和高剂量组（500 mg·kg-1），采用线栓法制备小鼠大脑中动脉栓塞模型（middle cerebral artery occlusion，MCAO），缺血2 h，再灌注24 h后观察葛根素对损伤后脑梗死体积、含水量、神经功能评分等指标的影响。根据再灌注不同时间点，溶剂对照组又分为2 h、6 h、12 h、24 h共 4个亚组，分别在相应时间点采用蛋白质免疫印迹技术测定脑组织中ER-α及HIF-1α的变化情况。取变化最显著的缺血2 h再灌注12 h这一时间点测定葛根素对ER-α及HIF-1α表达的影响，并通过酶联免疫吸附技术测定葛根素在这一时间点对下游炎症因子如肿瘤坏死因子α（tumor necrosis factor-α， TNF-α）、白细胞介素1β（interleukin-1β，IL-1β）和白细胞介素6（interleukin-6，IL-6）的调节作用。结果相比溶剂对照组，低、中和高剂量组葛根素均能降低缺血2 h再灌注24 h小鼠的脑梗死体积[低剂量（29.6±3.6）%，中剂量（15.2±3.9）%，高剂量（8.2±2.1）% vs 对照组（39.3±5.0）%] 和脑含水量[低剂量（84.9±8.8）%，中剂量（83.7±8.2）%，高剂量（80.9±8.7）% vs 对照组（85.3±10.2）%]，差异有统计学意义。对于脑缺血2 h再灌注12 h小鼠，中、高剂量葛根素组较溶剂对照组ER-α水平升高，HI F-1α水平降低，差异有统计学意义；中、高剂量葛根素组TNF-α（[ 420.7±27.2） μg·g-1，（379.6±23.9）μg·g -1] 、I L-1β[（211.8±19.2）μg·g-1，（182.4±13.5）μg·g -1]和I L- 6（[ 111.2±9.1）μg·g-1，（104.1±12.4）μg·g -1]水平较溶剂对照组[TNF-α（505.8±36.7）μg·g-1；IL-1β （291.6±21.8）μg·g-1；IL-6（138.4±11.7）μg·g-1] 下降，差异有统计学意义。结论葛根素在一定剂量范围内可降低脑缺血再灌注小鼠病变脑组织的含水量，减小梗死体积，其作用机制可能与激活ER-α、抑制HI F-1α表达并抑制相关炎症因子TNF-α、IL-1β和IL-6的释放有关。

文章导读： 本研究通过动物模型的对比研究证实葛根素能减少小鼠脑缺血再灌注后脑梗死体积，并提示葛根素的神经保护作用可能与其调节雌激素受体及缺氧诱导因子-1的表达及抑制相关炎症因子如肿瘤坏死因子α、白细胞介素1β和白细胞介素6的释放有关。

关键词: 葛根素；脑缺血再灌注；雌激素受体；缺氧诱导因子-1α ；炎性细胞因子

Abstract:

Objective To observe the neuroprotection of Puerarin on cerebral ischemia reperfusion injury and investigate its effect on the expression of estrogen receptor α (ER-α) , hypoxia inducible factor-1 (HIF-1α) and related inflammatory cytokines. Methods Mice were randomly divided into a sham group, a solvent-control group and three Puerarin-treated groups with different doses (100, 250, 500 mg·kg-1). Middle cerebral artery occlusion (MCAO) model was made and then the infarct volume, water content and neurological scores were evaluated after 2 h ischemia and 24 h reperfusion. Western blot was used to determine the expression of ER-α and HIF-1α after 2 h, 6 h, 12 h, 24 h reperfusion respectively. Both Western blot and ELISA were used to determine the effect of Puerarin on the expression of ER-α, HIF-1α and related inflammatory cytokines such as tumor necrosis factor-α (TNF- α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) in 2 h ischemia and 12 h reperfusion mice. Results Compared with solvent-control group, Puerarin reduced the infarct volume [low dose group (29.6±3.6)%, medium dose group (15.2±3.9)%, high dose group (8.2±2.1)% vs control group (39.3±5.0)%] and water content [low dose group (84.9±8.8)%, medium dose group (83.7±8.2)%, high dose group (80.9±8.7)% vs control group (85.3±10.2)%], which had significant difference. It also activated ER-α and suppressed HIF-1α. In addition, medium and high dose of Puerarin further inhibited TNF-α [(420.7± 27.2) μg·g-1, (379.6±23.9) μg·g-1], IL-1β [(211.8±19.2) μg·g-1, (182.4±13.5) μg·g-1] and IL-6 [(111.2±9.1) μg·g-1, (104.1±12.4) μg·g-1] respectively compared to solvent control group [TNF-α (505.8±36.7) μg·g-1; IL-1β (291.6±21.8) μg·g-1; IL-6 (138.4±11.7) μg·g-1] in 2 h ischemia and 12 h reperfusion mice. Conclusion Puerarin within certain range of doses could reduce the water content and infarct volume of cerebral ischemia reperfusion injury. Its mechanism might be linked to activation of ER-α, inhibition the expression of HIF-1α, and the inhibition of release of related inflammatory cytokines such as TNF-α, IL-1β and IL-6.

Key words: Puerarin; Cerebral ischemia reperfusion; Estrogen receptor; Hypoxia inducible factor-1α; Inflammatory cytokines

姜辰, 杨浩鹏. 葛根素对小鼠脑缺血再灌注损伤的神经保护作用及机制研究[J]. 中国卒中杂志, 2018, 13(01): 58-63.

JIANG Chen, YANG Hao-Peng. The Mechanism and Neuroprotection Study of Perarin on Cerebral Ischemia Reperfusion Injury in Mice[J]. Chinese Journal of Stroke, 2018, 13(01): 58-63.

参考文献

[1] HU X，DE SILVA T M，CHEN J，et al. Genetic

cerebral vascular disease and neurovascular injury

in ischemic stroke[J]. Circ Res，2017，120（3）：449-

471.

[2] JOVER-MENGUAL T，CASTELLÓ-RUIZ M，

BURGUETE M C，et al. Molecular mechanisms

mediating the neuroprotective role of the selective

estrogen receptor modulator，bazedoxifene，in

acute ischemic stroke：A comparative study

with 17β-estradiol[J/OL]. J Steroid Biochem Mol

Biol，2017，171：296-304. https：//doi.org/10.1016/

j.jsbmb.2017.05.001.

[3] MOZAFFARIAN D，BENJAMIN E，GO A S，et

al. Executive summary：heart disease and stroke

Statistics-2016 update[J]. Circulation. 2016，133（4）：

447-454.

[4] SHIN J A，YOON J C，KIM M，et al. Activation of

classical estrogen receptor subtypes reduces tight

junction disruption of brain endothelial cells under

ischemia/reperfusion injury[J/OL]. Free Radic Biol

Med，2016，92：78-89. https：//doi.org/10.1016/

j.freeradbiomed.2016.01.010.

[5] YAMAGUCHI R，KAMIYA N，ADAPALA N S，

et al. HIF-1-dependent IL-6 activation in articular

chondrocytes initiating synovitis in femoral head

ischemic osteonecrosis[J]. J Bone Joint Surg Am，

2016，98（13）：1122-1131.

[6] BALAMURUGAN K. HIF-1 at the crossroads of

hypoxia，inflammation，and cancer[J]. Int J Cancer.

2016，138（5）：1058-1066.

[7] HONGYUN H，TAO G，PENGYUE Z，et al.

Puerarin provides a neuroprotection against transient

cerebral ischemia by attenuating autophagy at

the ischemic penumbra in neurons but not in

astrocytes[J/OL]. Neurosci Lett，2017，643：45-51.

https：//doi.org/10.1016/j.neulet.2017.02.009.

[8] ZHENG Q H，LI X L，MEI Z G，et al. Efficacy and

safety of puerarin injection in curing acute ischemic

stroke：A meta-analysis of randomized controlled

trials[J]. Medicine（Baltimore），2017，96（1）：e5803.

[9] LONGA E Z，WEINSTEIN P R，CARLSON S，et al.

Reversible middle cerebral artery occlusion without

craniotomy in rats[J]. Stroke，1989，20（1）：84-91.

[10] 么晓轶，李颖. 植物雌激素对去势雌性大鼠缺血性

脑损伤的神经保护作用[J]. 中国神经免疫学和神经

病学杂志，2005，12（3）：160-163.

[11] 宋宏杉，何可立，汪建民，等. 葛根素对大鼠局灶性

脑缺血后雌激素受体α阳性神经元变化的影响[J]. 时

珍国医国药，2007，18（1）：127-129.

[12] JIANG M，YUN Q，NIU G，et al. Puerarin prevents

inflammation and apoptosis in the neurocytes of a

murine Parkinson’s disease model[J]. Genet Mol

Res，2016，15（4）：1-9.

[13] 刘照寒，曲松滨. 雌激素与女性缺血性脑卒中[J]. 现

代生物医学进展，2012，12（3）：195-197.

[14] 张志春，邹萍，黄亮，等. 雌激素受体在脑内的表达

与缺血再灌注损伤[J]. 生物技术通讯，2015，26（4）：

583-586.

[15] RUDOLPH L M，CORNIL C A，MITTELMANSMITH

M A，et al. Actions of Steroids：New

Neurotransmitters[J]. J Neurosci. 2016，36（45）：

11449-11458.

[16] ENDLER A，CHEN L，ZHANG J，et al. Binding of

the ERα and ARNT1 AF2 domains to exon 21 of the

SRC1 isoform SRC1e is essential for estrogen-and

dioxin-related transcription[J]. J Cell Sci，2012，125

（Pt 8）：2004-2016.

[17] KASIVISVANATHAN V，SHALHOUB J，LIM

C S，et al. Hypoxia-inducible factor-1 in arterial

disease：a putative therapeutic target[J]. Curr Vasc

Pharmacol. 2011，9（3）：333-349.

[18] DEHNE N，BRÜNE B. HIF-1 in the inflammatory

microenvironment[J]. Exp Cell Res，2009，315（11）：

1791-1797.